Fresenius: Shareholders Approve All AGM Resolutions
Fresenius SE Non-GAAP EPS of €0.82, Revenue of €5.74B; Reaffirms FY26 Outlook
Fresenius Posts Higher Revenue, Earnings on Growth Across Units
Analysts Saw Fresenius 1Q Revenue Before Special Items at EUR5.82B
Analysts Saw Fresenius 1Q Before Special Items at EUR681.4M
Fresenius Says 1Q Performance Fully in Line With Expectations
Fresenius 1Q Revenue Before Special Items EUR5.74B, With Organic Growth of 5%
Fresenius 1Q Core Net Profit EUR460M
Fresenius 1Q EBIT Before Special Items EUR678M
Fresenius Backs 2026 View
FRESENIUS SE & CO KGAA SPON ADR EA REP 0.25 ORD SHS (FSNUY.US) will release its earnings report on May 6.
FRESENIUS SE & CO KGAA SPON ADR EA REP 0.25 ORD SHS (FSNUY.US) is scheduled to release its earnings report on May 6. Investors are advised to pay attention. What about the previous performance? FRESENIUS SE & CO KGAA SPON ADR EA REP 0.25 ORD SHS (FSNUY.US) reported revenue of 5.961 billion euros, net profit of 361 million euros, and earnings per share of 0.158 euros in Q4 2025. In Q1 2025, the company's operating
DaVita Tops Chart as the Only Large-cap Healthcare Services Name Rated Strong Buy
Fresenius SE Co. KGaA Reports FY Results
Fresenius Renews CEO's Contract as Net Profit Jumps
Fresenius 4Q Net Pft EUR361M
Fresenius: Implications of U.S. Supreme Court Ruling on Tariffs Are Currently Being Evaluated
Fresenius: Supervisory Board Extended CEO Michael Sen's Contract by Five Years
Fresenius 4Q Adj EPS EUR0.78
Fresenius 4Q Rev EUR5.875B
Fresenius Sees 2026 Core EPS Growth in 5% to 10% Range